Cost-effectiveness of healthcare interventions for rare cancers: Evidence from a systematic literature review and meta-analysis
<strong>Background</strong> Rare cancers account for 20–24% of all cancer diagnoses in Europe and have been recently recognized as a public health issue due to the lower survival compared to common cancers. However, the evidence about the cost-effectiveness of interventions for rare canc...
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Journal article |
| Publicerad: |
Elsevier
2018
|